Krell Elizabeth D 4
4 · AtriCure, Inc. · Filed Mar 14, 2018
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Krell Elizabeth D
Director
Transactions
- Exercise/Conversion
Common Stock
2018-03-12$14.17/sh+10,000$141,700→ 29,967 total - Sale
Common Stock
2018-03-13$20.00/sh−10,000$200,000→ 19,967 total - Exercise/Conversion
Stock Option (right to buy)
2018-03-12−10,000→ 0 totalExercise: $14.17From: 2012-05-18Exp: 2021-05-18→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $19.88 to $20.15 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]These options were granted on May 18, 2011 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant.